About Biocorrx
BioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: BICX
- CUSIP:
Key Metrics:
- Previous Close: $0.04
- 50 Day Moving Average: $0.0483
- 200 Day Moving Average: $0.0307
- 52-Week Range: $166,094,000.00 - $0.02
- Trailing P/E Ratio: N/A
- P/E Growth: 0.0000
- Market Cap: $6.66M
- Outstanding Shares: 166,094,000
- Beta: -2.23
Additional Links:
Companies Related to Biocorrx:
Consensus Ratings for Biocorrx (OTCMKTS:BICX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Biocorrx (OTCMKTS:BICX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Biocorrx (OTCMKTS:BICX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Biocorrx (OTCMKTS:BICX)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Biocorrx (OTCMKTS:BICX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Biocorrx (OTCMKTS:BICX)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 2/27/2015 | Jorge Andrade Jr | Director | Sell | 125,000 | $0.06 | $7,500.00 |  |
| 2/26/2015 | Jorge Andrade Jr | Director | Sell | 245,000 | $0.05 | $12,250.00 | |
| 2/23/2015 | Jorge Andrade Jr | Director | Sell | 215,000 | $0.06 | $12,900.00 | |
| 2/17/2015 | Jorge Andrade Jr | Director | Sell | 90,000 | $0.08 | $7,200.00 | |
| 2/10/2015 | Jorge Andrade Jr | Director | Sell | 60,000 | $0.09 | $5,400.00 | |
| 10/28/2014 | Jorge Andrade Jr | Director | Sell | 25,000 | $0.09 | $2,250.00 | |
| 10/13/2014 | Jorge Andrade Jr | Director | Sell | 80,000 | $0.09 | $7,200.00 | |
| 10/7/2014 | Jorge Andrade Jr | Director | Sell | 40,000 | $0.11 | $4,400.00 | |
| 10/1/2014 | Jorge Andrade Jr | Director | Sell | 30,000 | $0.13 | $3,900.00 | |
| 9/29/2014 | Jorge Andrade Jr | Director | Sell | 170,000 | $0.10 | $17,000.00 | |
| 9/22/2014 | Jorge Andrade Jr | Director | Sell | 130,000 | $0.10 | $13,000.00 | |
| 9/15/2014 | Jorge Andrade Jr | Director | Sell | 90,000 | $0.10 | $9,000.00 | |
| 9/8/2014 | Jorge Andrade Jr | Director | Sell | 95,000 | $0.11 | $10,450.00 | |
| 8/22/2014 | Jorge Andrade Jr | Director | Sell | 100,000 | $0.13 | $13,000.00 | |
| 8/14/2014 | Jorge Andrade Jr | Director | Sell | 300,000 | $0.14 | $42,000.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Biocorrx (OTCMKTS:BICX)
Biocorrx (OTCMKTS:BICX) Chart for Monday, September, 26, 2016
